glucuronic acid has been researched along with Cardiac Remodeling, Ventricular in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, B; Ding, X; Ge, J; Jia, J; Lu, S; Qian, J; Shen, L; Shen, Y; Wu, Y | 1 |
| Bea, F; Frey, N; Leor, J; Linke, A; Müller-Ehmsen, J; Rosenberg, M; Schoors, D; Süselbeck, T; Tuvia, S; Vermeersch, P | 1 |
| Agathopoulos, S; Barka, E; Blankesteijn, WM; Daskalopoulos, EP; Kolettis, TM; Kontonika, M; Kouroupis, D; Mantzouratou, P; Pantos, C; Papalois, A; Tourmousoglou, C; Vilaeti, AD | 1 |
| Batich, CD; Byrne, BJ; Cogle, CR; Ferreira, LF; Handberg, EM; Huo, T; Pepine, CJ; Petersen, JW; Qi, Y; Rocca, DG; Rubiano, A; Ruchaya, PJ; Simmons, CS; Wate, PS; Willenberg, BJ; Wise, EA | 1 |
| Du, KT; Gu, Y; Lee, RJ; Mihardja, S; Sievers, RE; Yu, J | 1 |
| Castel, D; Cohen, S; Feinberg, MS; Goitein, O; Guetta, V; Klapper, L; Konen, E; Landa, N; Leor, J; Manczur, F; Petneházy, O; Shaul, M; Tsur-Gang, O; Tuvia, S; Willenz, U | 1 |
| Cohen, S; Harel-Adar, T; Ruvinov, E | 1 |
| Binsalamah, ZM; Khan, AA; Paul, A; Prakash, S; Shum-Tim, D | 1 |
| Cohen, S; Feinberg, MS; Freeman, I; Holbova, R; Landa, N; Leor, J; Miller, L; Shachar, M | 1 |
1 trial(s) available for glucuronic acid and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Intracoronary delivery of injectable bioabsorbable scaffold (IK-5001) to treat left ventricular remodeling after ST-elevation myocardial infarction: a first-in-man study.
Topics: Absorbable Implants; Adult; Aged; Alginates; Belgium; Calcium Gluconate; Feasibility Studies; Female; Germany; Glucuronic Acid; Heart Function Tests; Hexuronic Acids; Humans; Hydrogels; Injections, Intra-Arterial; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Predictive Value of Tests; Regenerative Medicine; Surveys and Questionnaires; Time Factors; Tissue Engineering; Tissue Scaffolds; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2014 |
8 other study(ies) available for glucuronic acid and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Delivery of alginate-chitosan hydrogel promotes endogenous repair and preserves cardiac function in rats with myocardial infarction.
Topics: Alginates; Animals; Apoptosis; Biocompatible Materials; Cell Proliferation; Chitosan; Disease Models, Animal; Fibrosis; Glucuronic Acid; Hexuronic Acids; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogels; Inflammation; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Regeneration; Regenerative Medicine; Shear Strength; Spectroscopy, Fourier Transform Infrared; Temperature; Tissue Engineering; Ventricular Remodeling | 2015 |
Attenuation of post-infarction remodeling in rats by sustained myocardial growth hormone administration.
Topics: Alginates; Animals; Glucuronic Acid; Growth Hormone; Hexuronic Acids; Hydrogels; Myocardial Infarction; Myocytes, Cardiac; Rats; Rats, Wistar; Tissue Scaffolds; Ventricular Remodeling | 2015 |
An injectable capillary-like microstructured alginate hydrogel improves left ventricular function after myocardial infarction in rats.
Topics: Alginates; Angiotensin I; Animals; Biocompatible Materials; Disease Models, Animal; Echocardiography; Gelatin; Glucuronic Acid; Hexuronic Acids; Hydrogels; Injections, Intralesional; Myocardial Infarction; Peptide Fragments; Rats; Rats, Sprague-Dawley; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2016 |
The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model.
Topics: Alginates; Animals; Cell Adhesion; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Female; Glucuronic Acid; Hexuronic Acids; Humans; Myocardial Infarction; Oligopeptides; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine.
Topics: Alginates; Animals; Biocompatible Materials; Disease Models, Animal; Feasibility Studies; Female; Glucuronic Acid; Heart Rate; Hexuronic Acids; Hydrogel, Polyethylene Glycol Dimethacrylate; Injections, Intralesional; Myocardial Infarction; Stroke Volume; Swine; Ventricular Remodeling | 2009 |
Bioengineering the infarcted heart by applying bio-inspired materials.
Topics: Alginates; Animals; Biocompatible Materials; Bioengineering; Disease Models, Animal; Drug Carriers; Extracellular Matrix Proteins; Glucuronic Acid; Hexuronic Acids; Injections; Intercellular Signaling Peptides and Proteins; Liposomes; Macrophages; Mice; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Phosphatidylserines; Rats; Regeneration; Regenerative Medicine; Time Factors; Tissue Scaffolds; Ventricular Remodeling | 2011 |
Intramyocardial sustained delivery of placental growth factor using nanoparticles as a vehicle for delivery in the rat infarct model.
Topics: Alginates; Analysis of Variance; Animals; Chitosan; Cytokines; Electrocardiography; Female; Glucuronic Acid; Hexuronic Acids; Immunohistochemistry; Myocardial Infarction; Nanoparticles; Neovascularization, Physiologic; Particle Size; Pharmaceutical Vehicles; Placenta Growth Factor; Pregnancy Proteins; Rats; Rats, Inbred Lew; Stroke Volume; Ventricular Remodeling | 2011 |
Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat.
Topics: Alginates; Animals; Biocompatible Materials; Cicatrix; Drug Administration Schedule; Drug Evaluation, Preclinical; Glucuronic Acid; Hexuronic Acids; Hydrogels; Hypertrophy, Left Ventricular; Injections, Intralesional; Male; Materials Testing; Myocardial Infarction; Myocytes, Cardiac; Random Allocation; Rats; Rats, Sprague-Dawley; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Remodeling; Viscosity | 2008 |